Ligands of HVEM for treating hematologic malignancies
US8318166B2 · kind B2 · utility
1Cited by
1References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 2, 2008 |
| Grant date | Nov 27, 2012 |
| Priority date | — |
| Expiry date | Jun 2, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to ligands of HVEM for the treatment of hematologic malignancies, in particular Chronic lymphocytic leukaemia, and for the treatment of autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.